I. Adcock (London, United Kingdom), L. Kistemaker (Groningen, Netherlands)
Late Breaking Abstract - RPL554, a first-in-class dual PDE3/4 inhibitor, causes significant bronchodilation and symptom relief; a Phase 2b COPD study
B. Maurer (New York, United States of America), D. Singh (Manchester, United Kingdom), F. Martinez (New York, United States of America), K. Newman (New York, United States of America)
|    |
Anti-inflammatory effects of the JAK inhibitor tofacitinib in two murine house dust mite -driven models of asthma.
A. Pisano (Parma, Italy), D. Miglietta (Parma, Italy), F. Bignami (Parma, Italy), A. Allen (Parma, Italy), M. Biagetti (Parma, Italy), G. Aquino (Parma, Italy), C. Carnini (Parma, Italy), M. Civelli (Parma, Italy), G. Villetti (Parma, Italy)
| |
Hydrogen sulphide donors prevent hyperreactivity of mice tracheas in an in vitro lipopolysaccharide-induced inflammation model
Y. Karaman-Kutluay (Ankara, Turkey), Y. Kaya-Yasar (Trabzon, Turkey), T. Bozkurt (Ankara, Turkey), I. Sahin-Erdemli (Ankara, Turkey)
|  |
Aerosolized TLR7 Imidazoquinoline Agonist Bronchodilates In Vivo
M. Drake (Portland, United States of America), B. Proskocil (Portland, United States of America), K. Lebold (Portland, United States of America), E. Blum (Portland, United States of America), A. Fryer (Portland, United States of America), D. Jacoby (Portland, United States of America)
| |
IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
J. Allinne (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), A. Agrawal (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), J. Kim (Tarrytown, United States of America), V. Kamat (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America)
| |
Targeting NADPH oxidase-2 reduces cigarette smoke-induced lung inflammation and skeletal muscle wasting in mice
I. Bernardo (Bundoora, Australia), S. Passey (Bundoora, Australia), H. Seow (Bundoora, Australia), S. Bozinovski (Bundoora, Australia), R. Vlahos (Bundoora, Australia)
| |
Efficacy of a novel PI3Kd inhibitor, DS-1515 in animal models of asthma
M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), S. Yamada (Tokyo, Japan), P. Chopra (Gurgaon, India), S. Sinha (Gurgaon, India), S. Singh (Gurgaon, India), H. Kalonia (Gurgaon, India), S. Wagh (Gurgaon, India), R. Shirumalla (Gurgaon, India), M. Diwan (Gurgaon, India)
| |